日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Grifola frondosa Polysaccharide F2 Ameliorates Disordered Glucose and Lipid Metabolism in Prediabetic Mice by Modulating Bile Acids

灰树花多糖F2通过调节胆汁酸改善糖尿病前期小鼠的葡萄糖和脂质代谢紊乱

Zhang, Ruifang; Xiao, Chun; Yong, Tianqiao; Huang, Longhua; Hu, Huiping; Xie, Yizhen; Wu, Qingping

Network Pharmacology-Based Elucidation of the Hypoglycemic Mechanism of Grifola frondosa GF5000 Polysaccharides via GCK modulation in Diabetic Rats

基于网络药理学的灰树花GF5000多糖通过调节GCK在糖尿病大鼠中发挥降血糖作用的机制研究

Xiao, Chun; Jiao, Chunwei; Huang, Longhua; Hu, Huiping; Xie, Yizhen; Wu, Qingping

Gene Editing in Ganoderma lucidum: Development, Challenges, and Future Prospects

灵芝基因编辑:发展、挑战与未来展望

He, Shiqi; Liu, Yuanchao; Zhang, Zhi; Cai, Manjun; Hao, Yufan; Hu, Huiping

Disproportionality Analysis of Renal Adverse Events Associated with a Combination of Immune Checkpoint Inhibitors and Acid-Suppressing Agents-A Pharmacovigilance Study Based on the FAERS Database

基于FAERS数据库的药物警戒研究:免疫检查点抑制剂与抑酸剂联合用药相关肾脏不良事件的比例失衡分析

Liu, Jinmei; Chen, Xu; Zhang, Cong; Hu, Huiping; Li, Shijun; Fu, Zhiwen; You, Ruxu

Efficacy of Encorelane in Enhancing Barrier Function and Reducing Aging Signs in Sensitive Skin.

Encorelane 在增强敏感肌肤屏障功能和减少衰老迹象方面的功效

Wang Lina, Wang Caixia, Jiang Liyuan, Hu Huiping, Wu Yuxuan, Li Yanan, Sun Peiwen

The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

恩格列净真实世界安全性概况:基于FDA不良事件报告系统(FAERS)数据库的不均衡性分析

Hu, Huiping; Liu, Maochang; Fu, Zhiwen; Li, Shijun; Wang, Kaiping; Huang, Zi

Factors influencing resilience and its relationship with spiritual coping strategies among nursing college students: a latent profile analysis

影响护理专业大学生心理韧性及其与精神应对策略关系的因素:潜在剖面分析

Hu, Shuang; Liu, Siying; Yang, Qizhi; Zhao, Ting; Shumaila, Batool; Xian, Yajing; Liu, Hongyang; Xu, Dandan; Hu, Huiping; Li, Xianhong

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3

SARS-CoV-2 BA.2.86/JN.1 和 EG.5.1/HK.3 的谱系特异性致病性、免疫逃避和病毒学特征

Yuanchen Liu #, Xiaoyu Zhao #, Jialu Shi #, Yajie Wang #, Huan Liu #, Ye-Fan Hu #, Bingjie Hu, Huiping Shuai, Terrence Tsz-Tai Yuen, Yue Chai, Feifei Liu, Hua-Rui Gong, Jiayan Li, Xun Wang, Shujun Jiang, Xiang Zhang, Yanliang Zhang, Xiangnan Li, Lei Wang, Madeline Hartnoll, Tianrenzheng Zhu, Yuxin H

Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy

靶向重编程肿瘤相关巨噬细胞以克服胶质母细胞瘤对化疗和免疫疗法的耐药性

Jianan Li, Jun Yang, Shaoping Jiang, Yunxin Tian, Yuquan Zhang, Lin Xu, Bo Hu, Huiping Shi, Zhaohan Li, Guangyao Ran, Yuanyu Huang, Shaobo Ruan

Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database

贝伐珠单抗相关治疗方案引起的肺出血和咯血:一项基于FAERS数据库的回顾性药物警戒研究

Hu, Huiping; Fu, Zhiwen; Liu, Jinmei; Zhang, Cong; Li, Shijun; Zhang, Yu; You, Ruxu